Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
Vancomycin-resistant enterococcal bacteremia (VRE-B) is a common nosocomial infection associated with significant morbidity and mortality. Daptomycin and linezolid are primary treatment options although definitive clinical data to assess comparative therapeutic effectiveness are lacking. This study...
| Published in: | Therapeutic Advances in Infectious Disease |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-02-01
|
| Online Access: | https://doi.org/10.1177/2049936119828964 |
